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erine proteases are proteolytic enzymes that are in-
volved in the regulation of various physiologi-
cal  processes. We generated mice lacking the
membrane-anchored channel-activating serine protease
(CAP) 1 (also termed protease serine S1 family member
8 [
 
Prss8
 
] and prostasin) in skin, and these mice died
within 60 h after birth. They presented a lower body
weight and exhibited severe malformation of the stratum
corneum (SC). This aberrant skin development was ac-
companied by an impaired skin barrier function, as
evidenced by dehydration and skin permeability assay
and transepidermal water loss measurements leading to
S
 
rapid, fatal dehydration. Analysis of differentiation mark-
ers revealed no major alterations in CAP1/
 
Prss8
 
-deﬁcient
skin even though the epidermal deﬁciency of CAP1/Prss8
expression disturbs SC lipid composition, corneocyte
morphogenesis, and the processing of proﬁlaggrin. The
examination of tight junction proteins revealed an absence
of occludin, which did not prevent the diffusion of subcuta-
neously injected tracer (
 
 
 
600 D) toward the skin surface.
This study shows that CAP1/Prss8 expression in the epi-
dermis is crucial for the epidermal permeability barrier
and is, thereby, indispensable for postnatal survival.
 
Introduction
 
Serine proteases carry out several physiological and cellular
functions ranging from degradation and digestive processes to
protein processing and tissue remodelling. Therefore, they are
implicated in a wide spectrum of physiological and pathophys-
iological conditions. They share a high degree of amino acid
sequence identity; in particular, they share the histidine-aspar-
tate-serine  residues that are necessary for catalytic activity,
which are present in highly conserved motifs. Membrane-bound
serine proteases are anchored either via a carboxy-terminal
transmembrane domain (type I), a glycosyl-phosphatidylinosi-
tol (GPI) linkage, or an amino-terminal proximal transmem-
brane domain (type II). The family of membrane-bound serine
proteases is rapidly increasing, which indicates that cell surface
proteolysis has emerged as an important mechanism for the
generation of biologically active proteins (for review see Netzel-
Arnett et al., 2003). Their physiological role remains poorly
understood. Members of the relatively small subfamily of GPI-
anchored serine proteases are very similar in length, ranging
from 310–370 amino acid residues, and contain a typical
amino-terminal secretory signal and a hydrophobic domain at
their carboxy terminus. These anchoring domains are imbedded
in the plasma membrane, whereas their serine protease domains
are oriented extracellularly (for review see Netzel-Arnett et al.,
2003). GPI-anchored proteins are widely distributed on plasma
membranes of eukaryotic cells. They have diverse roles and can
function as enzymes, cell adhesion molecules, cell surface anti-
gens, and membrane-bound receptors (Kinoshita et al., 1995).
We recently isolated channel-activating protease (CAP) 1
(also termed protease serine S1 family member 8 [
 
Prss8
 
]),
which presents the mouse homologue of the human prostasin.
CAP1/Prss8 is found in various mammalian tissues like semen,
the prostate gland, and skin (Vuagniaux et al., 2000). The physi-
ological role of this protein is largely unknown, although a de-
regulation of Prss8 expression is found in high-grade human
prostate, breast, and ovarian cancers (Takahashi et al., 2003;
Chen et al., 2004). Further roles of this serine protease have been
proposed for cellular growth, morphogenesis, and sodium ab-
sorption in the kidney and lung (for review see Rossier, 2004).
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Skin is the largest organ of the human body, and it func-
tions primarily as a barrier to the physical environment by
the skin’s relative impermeability to water, water-soluble
compounds, and pathogenic micro-organisms. The constant
thickness of the epidermis is maintained by a balance be-
tween the proliferation of keratinocytes in the basal layer and
desquamation from the surface of the stratum corneum (SC).
When this process is altered, xerotic and ichthyotic condi-
tions may arise (Pierard et al., 2000). In skin, proteinases and
protease inhibitors like gelatinase A, nexin-1, or SC chymot-
ryptic enzyme regulate hair growth and/ or cycling (Ekholm
and Egelrud, 1998; Sonoda et al., 1999; Karelina et al.,
2000). Mice that are deficient for the papainlike lysosomal
cystein protease cathepsin L exhibit structural changes of
hair follicles and altered epidermal differentiation (Bena-
vides et al., 2002).
Here, we study the consequences of CAP1/
 
Prss8
 
 defi-
ciency in epidermal function. These mice died early after birth
as a result of severe dehydration, thus demonstrating the in-
volvement of CAP1/Prss8 in the epidermal barrier function that
is indispensable for postnatal survival.
 
Results
 
Generation of mice lacking Prss8 in the 
epidermis
 
In the 
 
Prss8
 
-modified gene locus, exons 3–5, which contain
two essential residues of the catalytic triad (His85 and
Asp134), are flanked by 
 
loxP
 
 sites. In addition, deletion of ex-
ons 3–5 results in a frameshift and leads to a premature stop
codon in exon 6, thereby generating a truncated protein at the
carboxy terminus (Fig. 1 a). When such a truncated construct
as cRNA is coinjected with epithelial sodium channel
 
 
 
(ENaC)
subunits in 
 
Xenopus
 
 
 
laevis
 
 oocytes, activation of the ENaC-
mediated sodium transport is completely abolished (4.3-fold
vs. 0.88-fold induction of amiloride-sensitive I
 
Na
 
 in oocytes
coinjected with ENaC/CAP1 wild-type and ENaC/CAP1 trun-
cated cRNAs, respectively; 
 
n
 
 
 
  
 
21 oocytes, P
 
 
 
  
 
0.001). When
ENaC was coinjected with a 1:1 mixture of CAP1/
 
Prss8
 
 wild-
type and truncated cRNAs, no difference in ENaC-mediated
sodium current was observed, thus rendering unlikely any
dominant negative effect of the truncated CAP1/
 
Prss8
 
 cRNA
(unpublished data).
To ablate CAP1/Prss8 specifically in the epidermis, we
used keratin (K) 14–Cre recombinase transgenic mice with
one null (
 
 
 
) allele and one conditional allele (lox) at the 
 
Prss8
 
gene locus (Li et al., 2001; Rubera et al., 2002). In the epider-
mis, this resulted in a majority of cells lacking the 
 
Prss8
 
 wild-
type allele (Fig. 1 b, lane 2). No recombination was observed
in the dermis, brain (Fig. 1 b, lanes 3, 4, 7, 8, 11, and 12), lung,
heart (not depicted), or in mice lacking the Cre transgene (Fig.
1 b, lanes 5–8). CAP1/
 
Prss8
 
 mRNA transcripts were detected
in the skin and lung but were absent in the brain (Fig. 1 c,
lanes 4–9). Knockout mice lacked normal 
 
Prss8
 
 mRNA in the
epidermis, whereas transcripts were still detected in the lung
(Fig. 1 c). In control mice, CAP1/Prss8 expression was de-
tected in the top layers of the granular layer and in the transi-
tion between stratum granulosum (SG) and SC. In contrast,
CAP1/Prss8 protein was not detected in the skin of knockout
mice (Fig. 1 d).
 
Early postnatal lethality and skin 
abnormalities in mice lacking CAP1 in 
the epidermis
 
Genotype analysis of newborn offspring revealed a ratio that
was consistent with the Mendelian pattern of inheritance (Fig.
2 a, left). However, when a total of 119 animals from 10 litters
were genotyped at the weaning age, we could not detect
Figure 1. Generation of skin-specific Prss8-deficient mice.
(a) Scheme of wild-type, loxP, and   allele at the Prss8
gene locus. Coding (gray boxes) and noncoding se-
quences (white boxes); loxP sites, black triangles. PCR-
based genotyping was performed using primers A–C
(arrows). For RT-PCR analysis, primers F and G (arrows)
were used. (b) PCR analysis with primers A–C distin-
guishes between wild-type ( ; 379 bp), lox (413 bp),
and   allele (top). Note the shift of the Prss8
lox allele into
the   allele in epidermis from animals harboring the Cre
transgene (lanes 2 and 10). Detection of the Cre trans-
gene using Cre- and myogenin-specific primers (internal
control; bottom). (c) RT-PCR analysis using primers F and
G demonstrates absence of CAP1/Prss8 mRNA tran-
scripts (309 bp) in the knockout group (lane 1). Wild-type
CAP1/Prss8 plasmid (lane 11; positive control). The reac-
tion is controlled by detection of GAPDH transcripts. (d)
Immunohistochemistry using the affinity-purified CAP1/
Prss8 antibody revealed expression in top layers of the
SG and in the transition between SG and SC in the con-
trol group (top), but absence of expression in the knock-
out (KO) group (bottom). BF, bright field; E, epidermis;
D, dermis; dotted lines, basal membrane. 
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Prss8
 
lox/
 
 
 
/K14-Cre
 
 animals (Fig. 2 a, right). This was further
investigated by monitoring 56 pups (
 
n
 
 
 
  
 
4 litters) during 72 h
after birth (Fig. 2 b). None of the 18 genotyped epidermis-
specific CAP1/
 
Prss8
 
 knockouts was found alive 
 
 
 
60 h after
birth, demonstrating that CAP1/Prss8 expression in skin is
indispensable for early postnatal survival.
Except for the difference in size (nose-caudal extremity),
we observed no gross abnormalities at birth (unpublished
data). The body weight of newborn knockout mice (1,207 
 
 
 
19 mg; 
 
n 
 
  
 
4) was lower than that of control mice (1,472 
 
 
 
36 mg; 
 
n 
 
  
 
3; P
 
 
 
  
 
0.001). After a few hours, the skin ap-
peared more reddish and wrinkled (Fig. 2 c). On the histolog-
ical level, all skin layers were present, but the SC was dis-
organized, more compact, and focally detached from the
granular layer, thus presenting an orthokeratotic hyperkerato-
sis phenotype (Fig. 2 d, bottom). The adnexal part of the skin
presented a dysmaturation of the hair follicles, which were
reduced in number and were incompletely matured. Hair fol-
licles were shorter, and no keratin was visible. Except for
medullar hypoplasia in the thymus, whole examination of
various organs revealed no further abnormalities (unpub-
lished data).
Figure 2. Early postnatal lethality and skin abnormalities
in Prss8
lox/ /K14-Cre mice. (a) Distribution of genotypes
in the knockout (black bar) and control groups (white,
light gray, and dark gray bars) at birth indicated in per-
centages. From a total of 131 pups (n   14 litters) that
were analyzed shortly after birth, 28 were from the
knockout group, 32 were from Prss8
lox/ , 40 were from
Prss8
lox/ , and 31 were from Prss8
lox/ /K14-Cre (control
group; expected distribution in percentage; dotted line).
At weaning, 37 Prss8
lox/ , 37 Prss8
lox/ , and 44
Prss8
lox/ /K14-Cre mice were identified. ***, P  
0.001. (b) Survival curves of knockout (black squares)
and control mice (white diamonds and gray squares).
Note that no knockout mice survived 60 h after birth. (c)
Representative example showing different sizes of knock-
out (right) and control (left) littermates. (d) Representative
skin sections from newborn control (top) and knockout
(bottom) littermates stained with hematoxylin and eosin.
Staining (left) shows abnormal SC formation and a re-
duced hair follicle number in knockout skin. Higher mag-
nification (right) reveals an orthokeratotic hyperkeratosis
and dysmaturation of hair follicles.
Figure 3. Disruption of epidermal barrier func-
tion in Prss8
lox/ /K14-Cre mice. (a) Dehydra-
tion assay over time. Data are presented as
percentages of initial body weight in knockout
(black squares; n   5) and control (Prss8
lox/ 
and  Prss8
lox/ / K14-Cre; white diamonds
and gray squares; n     5–8) mice. *, P   
0.05; ***, P    0.001. (b) Transepidermal
water loss (TEWL) measured on ventral skin is
decreased in Prss8
lox/ /K14-Cre (black bar;
n     6) pups compared with control pups
(Prss8
lox/ , light gray bar; n   9), Prss8
lox/ /
K14-Cre (dark gray bar; n   11), and Prss8
lox/ 
(white bar; n   15). **, P   0.01; ***, P  
0.001. Error bars represent SEM. (c) Barrier-
dependent dye exclusion assay in knockout
(left; n   8) and control (right; n   5) pups.
Representative photograph revealing dye pene-
tration of all epidermal surfaces, especially ven-
trally in knockout, but not in control, pups.JCB • VOLUME 170 • NUMBER 3 • 2005 490
Impairment of the epidermal barrier 
function
Next, we tested the functional integrity of the epidermis by
measuring the inwards and outwards barrier function. As illus-
trated in Fig. 3 a, knockout mice severely lost more weight than
their littermates (10% in 6 h vs. 2–3% in the control group),
which is interpreted as liquid loss by evaporation through the
skin. Increased dehydration was further confirmed in these
mice by measuring the transepidermal water loss (TEWL),
which increased by almost 40% in neonates from the knockout
group (Fig. 3 b). These mice also showed increased toluidine
blue penetration across the entire epidermal surface and more
especially at the ventral side, whereas controls were completely
unstained (Fig. 3 c). This severe impairment of both inwards
and outwards barrier functions of the epidermis in knockout
animals strongly suggests the involvement of CAP1/Prss8 in
epidermal barrier function.
Altered morphogenesis of corneocytes 
and defective epidermal lipid matrix 
composition
Components of the SC, corneocytes, and epidermal lipid ma-
trix were further analyzed. The morphology and resistance to
mechanical stress of isolated corneocytes was assessed. As in
controls, the number of fragilized cells that were resistant to
ultrasound treatment after sonication increased but was not
significantly different with time. However, cells from the
knockout group exhibited an  10% larger surface, indicating
a perturbation of the morphogenesis of corneocytes (Fig. 4 a;
P   0.001). The surface appearance and shape of these cells
were not altered (Fig. 4 b), and the lipid content of isolated
SC (dry weight) was slightly reduced (Fig. 4 c; 80 vs. 103  g/
mg in control; n   5). Densitometric quantification of cer-
amides and glucosylceramides revealed no changes except for
the amount of ceramide (Cer)AS (15 vs. 10  g/mg dry SC
weight in the control group; P  0.05). The lipid barrier pre-
cursor sphingomyelin increased 3.7-fold (Fig. 4 d; P   
0.001). The lipid content of covalent-bound lipids is impor-
tant for the barrier function (Macheleidt et al., 2002), and, in
knockout epidermis, the level of bound  -hydoxylated fatty
acid decreased by 50%, whereas the fatty acid level in-
creased by 56% (Fig. 4 e). Furthermore, the amount of co-
valently bound Cer(OS) (ceramides with a  -hydroxy fatty
acid and sphingosine groups) significantly decreased by 27%
(Fig. 4 e). These data implicated CAP1/Prss8 in the morpho-
genesis of corneocytes and in the composition of the lipid
matrix in the SC.
Figure 4. Enlarged corneocytes and altered SC lipid composition in knock-
out mice. (a) Mean surface area of cells from control (white bar; n   15–50
corneocytes; n   6 mice) and knockout (Exp) mice (black bar; n   15–50
corneocytes; n   5 mice). ***, P   0.001. (b) Morphological appear-
ance of purified cells that are isolated from the control (left) and knockout
(right) epidermis. (c) Levels of main free SC lipids. Chol, cholesterol; FFA,
free fatty acid; Cer, ceramides. (d) Analysis of probarrier lipids. Note the
increased amount of sphingomyelin (SM) in the knockout group (***, P  
0.001), whereas levels of different glucosylceramide fractions (GlcCer c,
GlcCer a/b, and GlcCer(EOS); N-acyl fatty acid acylated in  -OH position)
were unaltered. (e) Level of covalently bound lipids. Note the 50% re-
duced amount of  -hydroxylated fatty acid ( -OH–FA; ***, P   0.001),
the decrease in ceramides (Cer[OS]); *, P   0.05), and the significantly
increased fatty acid (FA; **, P   0.01) levels in knockout (Prss8
lox/ /K14-
Cre; black bar) versus control (Prss8
lox/ ; white bar) groups. Each value is
the mean of five animals   SEM (error bars).
Figure 5. Aberrant profilaggrin to filaggrin processing in Prss8-deficient
epidermis. (a) Equal amounts of protein extracts of control (lanes 1 and 3)
and knockout (lanes 2 and 4) epidermis were separated through SDS-
PAGE under reducing conditions and either were Coomassie blue stained
(loading control; lanes 1 and 2) or subjected to Western blot analysis using
the anti-filaggrin antibody (lanes 3 and 4). Note the aberrant profilaggrin
to filaggrin processing in the knockout epidermis with a nearly complete
loss of 25-kD filaggrin monomers (lane 4). The position of profilaggrin
(proF) and its proteolytically-derived products (F; e.g., filaggrin three-
domain [3F] and two-domain [2F] intermediates) are indicated. The size
of the molecular marker (kD) is also indicated. (b) Western blot analysis
on epidermal proteins from control (Ctrl) and knockout (KO) mice after
SDS-PAGE separation using differentiation markers (loricrin, 57 kD; K1, 67 kD;
K14, 55 kD; and involucrin, 56 kD; indicated by arrow). Equal amounts
of the proteins were loaded.SEVERE EPIDERMAL BARRIER DEFECT IN CAP1/PRSS8-DEFICIENT MICE • LEYVRAZ ET AL. 491
Defective profilaggrin to filaggrin 
processing but otherwise normal 
expression of differentiation markers
To unveil defects in differentiation that are caused by CAP1/
Prss8 deficiency, we analyzed the level of expression and dis-
tribution of differentiation markers. Western blot analysis of
epidermal proteins revealed a normal profilaggrin to filaggrin
processing pattern in the control epidermis. Intermediates from
profilaggrin (300 kD) to filaggrin monomers ( 25 kD) dif-
fered in size (Fig. 5 a). In contrast, the epidermis lacking CAP1
presented an aberrant pattern of profilaggrin-derived proteolytic
products, mainly the two-domain intermediate ( 50 kD), which
is composed of two monomers of filaggrin. In addition, we
found a nearly complete loss of filaggrin monomer ( 25 kD)
in Prss8-deficient epidermis (Fig. 5 a). On the other hand, im-
munofluorescence showed a comparable distribution of the fil-
aggrin expression in both genotypes (Fig. 6). Western blot and
immunofluorescence microscopy analysis revealed a normal
expression of K14 and no obvious differences in K1, loricrin,
and involucrin (Figs. 5 and 6). Both the control and knockout
epidermis were clearly negative for K6 (Fig. 6).
Impaired barrier function of tight 
junctions (TJs) in the epidermis
To understand the epidermal barrier defect that is caused by
CAP1/Prss8 deficiency, we further analyzed the TJ proteins clau-
din-1, occludin, and ZO-1 (Zonula occludens 1) in the control
and knockout group because an important part of the water bar-
rier is formed by TJs. Localization of claudin-1 (Brandner et al.,
2002; Furuse et al., 2002) was not affected and detected in the
stratum spinosum or in the lower SG layers (Fig. 7). ZO-1 was lo-
calized in the cell periphery of SG cells and seemed to be slightly
dispersed in the knockout group (Fig. 7). Occludin appeared as
spots in the second layer of SG cells (Fig. 7 a, arrows) as ex-
pected from a TJ sealing of the epidermis. However, no expres-
sion of occludin was found in the CAP1/Prss8-deficient epider-
Figure 6. Normal distribution of the differentiation
markers in CAP1/Prss8-deficient epidermis. Immunofluo-
rescence LSM for filaggrin, loricrin, involucrin, K1, K6,
and K14. Nuclei are counterstained with DAPI. Bright-
field/DAPI is equally depicted, with the dotted lines indi-
cating the basal membrane. Filaggrin is mainly localized
in the SC but starts in the SG. Loricrin staining is ob-
served in the top SG and continues in the SC. Involucrin
staining is strong in the SC but is also expressed in the
SG and expressed slightly in the stratum spinosum. K1 is
localized from the SP to the SG (intermediate epidermis
marker). K6 is not detectable in both control and knock-
out groups. K14, which is a specific marker for the stratum
basale, is localized as expected in the two groups.JCB • VOLUME 170 • NUMBER 3 • 2005 492
mis (Fig. 7 a). To further examine whether this affects the barrier
function of TJs, we performed a tracer experiment as previously
described (Chen et al., 1997; Furuse et al., 2002). In control mice,
streptavidin labeling of the biotinylation tracer revealed a diffu-
sion through the paracellular spaces from stratum basale to the
second layer of SG. This diffusion was abruptly prevented at the
“ending” points, where occludin is supposed to be localized (Fig.
7 b, top). In contrast, in CAP1/Prss8-deficient epidermis, the
tracer appeared to pass this point and reach the interface between
the SG and corneum, where it accumulated (Fig. 7 b, bottom).
These findings clearly indicate that TJ function, at least against
small molecules of  600 D, was severely affected in the knock-
out epidermis and suggest that the impaired TJ barrier might be
causative for rapid and fatal dehydration in these mice.
Discussion
To study the role of GPI-anchored serine protease CAP1/
Prss8 in vivo, we used keratinocyte-specific gene targeting of
a conditional CAP1/Prss8 allele (Li et al., 2001; Rubera et
al., 2002). Disruption of the Prss8 gene locus was confined to
the epidermis and to K14-expressing epithelia (e.g., the thy-
mus and tongue; Fig. 1 and not depicted). Histopathological
analyses in the skin of CAP1/Prss8-deficient neonates revealed
a striking malformation of the SC that was accompanied by de-
fective epidermal barrier function, resulting in severe dehydra-
tion and early neonatal lethality (Fig. 2). Interestingly, the
observed cutaneous phenotype mostly resembled defects in
epidermal barrier function, as seen in mice that were defi-
cient in Klf4 (Krüppel-like factor 4) transcription factor,
the transglutaminase I gene, the matriptase/membrane-type
serine protease 1 (MT-SP1) gene, or the epidermal-specific
GPI anchor (pig-a) gene (for review see Segre, 2003). It is
known that proteolytic processing is required for signaling,
proprotein activation, structural remodeling, and desquamation.
Proteases such as calpain-1 (Yamazaki et al., 1997), furin
(Pearton et al., 2001), PEP1 (profilaggrin endopeptidase 1;
Resing et al., 1995), and matriptase/MT-SP1 (List et al.,
2003) have been identified as being directly implicated in
profilaggrin processing.
Identification of the molecular nature of the barrier is still
under investigation, with the consensus that a protein lipid
layer, which is located in the top layers of the epidermis and
TJs, plays an essential role in development of the skin barrier
function (Tsuruta et al., 2002). Evidence that cornified enve-
lope assembly is necessary for barrier development in skin is
obtained from the study of transglutaminase 1–deficient mice
that lack confirmed envelopes. These mice suffer from water
loss, resulting in neonatal lethality (Matsuki et al., 1998). Al-
terations of corneocyte morphology have also been described
in various mouse models with epidermal permeability barrier
defects ranging from near absence in transglutaminase 1–defi-
cient mice (Matsuki et al., 1998) to irregular shaped corneo-
cytes (e.g., Klf4 /  mice; Segre et al., 1999). Our corneocyte
phenotype mostly resembled that of matriptase/MT-SP1–defi-
cient mice, a member of the type II transmembrane serine pro-
tease family (List et al., 2003). Equally, mice with a targeted
disruption of Fatp4 (fatty acid transport protein 4) showed a
disturbed fatty acid composition of epidermal ceramides with a
normal distribution of TJ proteins (Herrmann et al., 2003), al-
though a functional TJ assay has not been performed. In the
CAP1/Prss8-deficient epidermis, the level of barrier-forming
lipids with very long chain fatty acids that were covalently
attached to proteins was significantly reduced, suggesting a
potential cause for the observed defect in epidermal barrier
permeability (Fig. 4). These barrier lipids were formed by mice
only a few days before birth (Doering et al., 2002), and their
deficiency in prosaposin- and  -glucocerebrosidase knockout
mice resulted in disruption of the water permeability barrier
and in early death (Doering et al., 1999a,b). Interestingly, the
observed imbalance in ceramide composition did not result
from an altered keratinocyte differentiation, as epidermal differ-
Figure 7. Expression of TJ proteins and TJ permeability assay. (a) Immuno-
fluorescence LSM for claudin-1 (claudin), Zonula occludens 1 (ZO-1), and
occludin. For ZO-1 and occludin, the DAPI counterstaining is added. The
two dotted lines show the basal membrane (bottom) and the limit SG/SC
(top). Claudin staining is localized in the whole epidermis except for the
SC and the last layer of SG in both groups. ZO-1 shows a staining in the
mid-SG in both groups. In controls, occludin shows a dotted staining, as
expected for TJs (arrows), between the second and last layer of the SG.
No such staining could be observed in knockouts. (b) TJ permeability as-
say visualized by LSM. For each genotype, the staining for streptavidin/
AlexaFluor488 is shown with DAPI counterstaining, and brightfield/DAPI
of the same picture is added for localization. The bottom dotted line indi-
cates the basal membrane, and the top line indicates the limit SG/SC. The
top panels show the diffusion of biotin in controls, which is blocked
abruptly between the second and last layer of the SG (arrow). The magni-
fication (inset, arrow) indicates the position of TJ. The bottom panel shows
the diffusion of biotin in knockout epidermis, which is not blocked by the
TJ and, thus, extends up to the SC, where it accumulates.SEVERE EPIDERMAL BARRIER DEFECT IN CAP1/PRSS8-DEFICIENT MICE • LEYVRAZ ET AL. 493
entiation markers (K14, K1, involucrin, loricrin, and filaggrin)
seemed not to be affected (Fig. 6). Defective profilaggrin to fil-
aggrin processing, as seen in the CAP1/Prss8 knockout group,
may lead to abnormal SC hydration, which further results in the
downstream depletion of humectant amino acids and their de-
iminated products (Fig. 5; Elias, 2004; for review see Rawlings
and Harding, 2004). At the transition between the granular
layer and SC, the processing of profilaggrin, which consists of
multiple filaggrin repeats joined by linker peptides, involves
dephosphorylation and proteolytic steps through three-domain
and two-domain intermediates to filaggrin (Fig. 5; Resing et
al., 1984). According to the proposed consensus site for pro-
teolytic cleavage by CAP1 (Shipway et al., 2004), two pre-
ferred polybasic cleavage sites are situated within filaggrin,
thus suggesting a mechanism for CAP1 activation.
Moreover, TJs are important for barrier function (Furuse
et al., 2002), indicating that two systems for forming a barrier
exist in skin. Indeed, CAP1/Prss8-deficient mice exhibited an
altered composition of lipids, precursors, and defective filag-
grin processing but also exhibited an impaired function of TJ,
thus leading to a severely compromised epidermal permeabil-
ity barrier that likely accounted for early neonatal death. Inter-
estingly, the link between protease action and TJ disruption
has been made by the treatment of epithelial cell lines with
Derp1, a cysteine protease that reversibly disrupts TJs (Wan
et al., 1999). Apparently, Derp1 acts to increase paracellular
permeability by direct proteolytic cleavage of occludin and
possibly claudin. This proteolysis is assumed to cause the
breakdown of the TJ protein complex. In CAP1/Prss8-defi-
cient epidermis, occludin seems to be absent from these TJs
despite the normal presence of claudin-1 and ZO-1 (Fig. 7 a).
Interestingly, mice lacking occludin show a complex pheno-
type, and the TJs themselves are not affected morphologically
and functionally (Saitou et al., 2000). By sequence compari-
son, we found a CAP1-preferred polybasic cleavage site in
ZO-1 but not in occludin protein, suggesting that the mecha-
nism of protease action on occludin may be indirect (unpub-
lished data). Nevertheless, the diffusion of injected biotinylation
reagent was not prevented, suggesting that the assembly of TJ
proteins to functional units is crucial. Thus, the TJ complex
may not be that different from wild-type mice, as supported
by claudin-1 and occludin-deficient mice (Saitou et al., 2000;
Furuse et al., 2002).
The physiological role of most of the membrane-anchored
serine proteases is still unclear, and the endogenous targets
of the majority of these enzymes have not been identified.
Matriptase/MT-SP1 has been proposed to initiate signaling and
proteolytic cascades through its ability to activate cell surface–
associated proteins like pro-uPA and PAR-2, although an inap-
propriate processing of these substrates might not contribute to
the epidermal phenotype of matriptase/MT-SPI–deficient mice
(Takeuchi et al., 2000; List et al., 2002). In vitro and in vivo
experiments indicated that membrane-bound serine proteases
may be of importance in the activation of the highly amiloride-
sensitive sodium channel ENaC (Rossier, 2004). These ser-
ine proteases include Prss8 (CAP1 or prostasin), TMPRSS4
(CAP2), matriptase/MT-SP1 (epithin or CAP3), and TMPRSS3
(Vallet et al., 1997; Vuagniaux et al., 2000, 2002; Guipponi et
al., 2002). As evidenced by RNA and protein analyses, ENaC
subunits are expressed in keratinocytes, whereas the dermis is
negative (Brouard et al., 1999). Interestingly, ENaC and CAP1/
Prss8 mRNA transcript expression was found in nondifferenti-
ated keratinocytes (Oda et al., 1999) and increased  2.2-fold
in more differentiated keratinocytes, as evidenced by real-time
PCR (unpublished data). In extracellular domains of the   and
  subunits of ENaC, CAP1-preferred polybasic cleavage sites
were recently found, suggesting a direct interaction with this
protease (Shipway et al., 2004). Therefore, ENaC may present
a potential substrate for CAP1 (Hughey et al., 2003, 2004), al-
though it is unlikely that ENaC is the only substrate of CAP1.
Newborn mice, in which ENaC activity had been deleted, dem-
onstrated epithelial hyperplasia, abnormal nuclei, premature se-
cretion of lipids, and abnormal expression of differentiation
markers. This finding suggests that this channel modulates
ionic signaling for specific aspects of epidermal differentiation,
such as synthesis or processing of differentiation-specific pro-
teins, and lipid secretion (Mauro et al., 2002). It will be inter-
esting to analyze TJs in these knockout mice. Membrane-
bound serine proteases might exhibit pleiotropic functions in
the activation of growth factors or G protein–coupled receptors
and in the activation of proteolytic cascades. A comparison of
the skin phenotypes of CAP1/Prss8- with matriptase/MT-SP1–
deficient mice indeed suggests that both serine proteases may
participate in the same protease-signaling cascade.
In humans, defective epidermal barrier function is seen
in a variety of skin disorders that are generally presumed to
be ichthyosis. Interestingly, the phenotype of our epidermis
CAP1/Prss8-deficient mice strikingly resembles a severe form
of congenital ichthyosis, the harlequin disease. Harlequin ich-
thyosis is an autosomal recessive human disorder affecting
skin cornification, and affected infants often die within days to
weeks of birth, apparently as a result of massive hyperkerato-
sis and/ or a severe epidermal permeability barrier defect (for
review see Dale and Kam, 1993). A “harlequin-like” mouse
showed mutations in cystatin M/E, which is a serine protease
inhibitor and substrate for transglutaminase, but no gene mu-
tations have been identified so far in harlequin ichthyosis pa-
tients (Zeeuwen et al., 2003). Recently, analysis of a pig-a
epidermis-specific knockout mouse suggested that defective
GPI-anchored proteins may account for harlequin ichthyosis
(types I and II) in humans (Hara-Chikuma et al., 2004). Al-
though the X-linked pig-a gene has been excluded, CAP1/
Prss8 may represent a candidate gene for this disease. This
study may facilitate further analysis of the role of this mem-
brane-anchored serine protease in normal skin development,
the identification of putative target proteins, and its implica-
tion in genetic disorders.
Materials and methods
Animals 
Mice carrying one knockout allele of Prss8 (Prss8
 ) were obtained by
breeding Prss8
tm1.2Hum (hereafter Prss8
lox) mice to EIIa-Cre (Lakso et al.,
1996) mice. To produce Prss8 mutant mice in which CAP1/Prss8 was se-
lectively disrupted in the epidermis, heterozygous mutant Prss8
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were crossed with K14-Cre mice (provided by D. Metzger and P. Cham-
bon, Institut de Genetique et de Biologie Moleculaire et Cellulaire, Ill-
kirch, France; Li et al., 2001). Epidermis-specific CAP1/Prss8-defi-
cient (Prss8
lox/ /K14-Cre, knockout group) and heterozygous mutant
(Prss8
lox/ / K14-Cre and Prss8
 /lox, control group) littermates were ob-
tained by interbreeding double transgenic male Prss8
 / /K14-Cre with
female  Prss8
loxlox mice. All experiments were performed coded. Mice
were housed and fed according to federal guidelines, and the local au-
thorities approved all procedures.
Genotyping was performed by using DNA-based PCR analysis from
biopsies (tail and organs) and was analyzed by PCR using the following
three primers: Prss8 sense, A (5 -GCAGTTGTAAGCTGTCATGTG-3 );
Prss8 sense, B (5 -CAGCAGCTGAGGTACCACT-3 ); and Prss8 antisense,
C (5 -CCAGGAAGCATAGGTAGAAG-3 ) to detect Prss8 wild-type– (379
bp), lox- (413 bp), and  -specific (473 bp) PCR-amplified products. 36 cy-
cles were run, each consisting of 1 min at 94, 56, and 72 C. The pres-
ence of the Cre transgene was detected by PCR using Cre-specific prim-
ers (sense, 5 -CCTGGAAAATGCTTCTGTCCG-3 ; and antisense, 5 -
CAGGGTGTTATAAGCAATCCC-3 ) to amplify a 350-bp fragment (36 cy-
cles were run as described above). Myogenin-specific primers (sense, 5 -
TTACGTCCATCGTGGACAGC-3 ; and antisense, 5 -TGGGCTGGGTGT-
TAGTCTTA-3 ) were used to control the DNA integrity of each sample.
For reverse transcription PCR, total RNA was isolated, extracted
from newborn mouse tissues (RNeasy Mini Kit; QIAGEN), and reverse
transcribed (Superscript II; Invitrogen) as described previously (Olivier et
al., 2002). PCR amplification was performed with primers situated in ex-
ons 4 and 6 of Prss8 (exon 4 sense, F [5 -CAGCCAATGCCTCCTTTCCC-
3 ]; and exon 6 antisense, G [5 -TCACCCCAACTCACAATGCC-3 ]). 40
cycles (each consisting of 1 min at 95, 57, and 72 C) were run to amplify
a Prss8-specific mRNA fragment of 309 bp. GAPDH primers (sense, 5 -
CGTCTTCACCACCATGGAGA-3 ; and antisense, 5 -CGGCCATCACGC-
CACAGTTT-3 ) were used as loading controls. Amplified PCR products
were separated on a 2% agarose gel and were visualized by ethidium
bromide staining.
Histopathological analysis and immunohistochemistry
For complete histopathological analysis, whole newborn litters from knock-
out and control groups were fixed overnight in 4.5% phosphate-buffered
formalin, pH 7, and were embedded in paraffin. 4- m sagittal sections
were stained with hematoxylin and eosin and were examined by light mi-
croscopy using a photomicroscope (Axioplan; Carl Zeiss MicroImaging,
Inc.). Images were acquired with a high sensibility digital color camera
(AxionHRc; Carl Zeiss MicroImaging, Inc.).
Immunohistochemistry was performed on newborn skin samples
that were frozen in optimum cutting temperature compound (Sakura
Finetek). Affinity-purified CAP1/Prss8 rabbit antiserum (Planes et al.,
2005) was incubated for 1 h at RT on 10- m cryosections that were previ-
ously fixed for 10 min in 4% PFA. Staining was visualized by laser scan-
ning microscopy (LSM) with a confocal microscope (model LSM510 Meta;
Carl Zeiss MicroImaging, Inc.) after 45 min of incubation at RT with CY3
anti–rabbit IgG (Jackson ImmunoResearch Laboratories). Mouse antibod-
ies to K6 (clone Ks6.KA12; Progen Biotechnik GmbH), K14, K1, involu-
crin, loricrin, and filaggrin were purchased from Covance and were used
at a dilution of 1:1,000 except for K14 (1:4,000).
Antibodies against TJ proteins.  Rabbit anti–claudin-1 pAb (Zymed
Laboratories) was used (1:100 dilution) in combination with CY3 anti–
rabbit IgG (Jackson ImmunoResearch Laboratories). mAb antioccludin
(MOC37) and ZO-1 (T8-754) were provided by M. Furuse (Kyoto Univer-
sity, Kyoto, Japan) and were combined with FITC-conjugated anti–mouse
antibodies (Calbiochem). After fixation (30 min in 95% ethanol at 4 C
and 1 min in acetone at RT) and permeabilization (10 min in 0.2% Triton
X-100/PBS), the incubation of cryosections with primary antibody was
performed overnight at 4 C after blocking 30 min in PBS/3% BSA, and
the reaction was revealed with secondary antibody for 2 h at 4 C. Nuclei
were counterstained with 0.2  g/ml DAPI in mounting medium.
Epidermal protein extraction and Western blot analysis
The epidermis and dermis were separated by heating the skin for 5 min at
54 C in 5 mM EDTA/PBS. Then, the epidermis was homogenized in ice-
cold 1 M NaSCN, 50 mM Hepes, 10 mM EDTA, pH 6.8, 0.3 mM ortho-
phenantroline, 20  g/ml PMSF, and 0.1% isopropanol (Resing et al.,
1984), and the lysate was cleared by centrifugation at 12,000 g for 15
min at 0 C after adding 10 vol of ice-cold water. 50  g of proteins were
separated by SDS-PAGE on 4–16% acrylamide gradient gels. Antibodies
were detected with donkey anti–rabbit IgG at a dilution 1:10,000 (GE
Healthcare), and the signal was developed with the Supersignal West
Dura System (Pierce Chemical Co.). Western blot analysis was performed
by using rabbit antibodies to filaggrin (1:1,000; Covance), loricrin
(1:1,000), K1 (1:1,000), K14 (1:10,000), and involucrin (1:1,000).
Lipid analysis
Whole skin from newborns were removed at autopsy, frozen, and stored
at  20 C until further treatment. SC preparation, lipid analysis, and re-
covery/analysis of covalently bound lipids was performed as described
previously (Reichelt et al., 2004).
Functional analyses of the epidermal barrier
Skin permeability assay.  Newborn mice from knockout and control
groups were killed and subjected to methanol dehydration and subse-
quent rehydration as described previously (Koch et al., 2000). They were
further washed in PBS, stained overnight at 4 C in 0.1% toluidine blue/
PBS (Merck), destained in PBS, and photographed with a digital camera
(Coolpix 950; Nikon; List et al., 2002).
Measurement of TEWL. The rate of TEWL from the ventral skin of
newborn mice was determined by using a Tewameter (Courage and
Khazaka) as described previously (Barel and Clarys, 1995; Matsuki et
al., 1998).
Dehydration assay. To determine the rate of fluid loss (List et al.,
2002), newborns from three independent litters were separated from their
mother to prevent fluid intake, and the rate of epithelial water loss was cal-
culated by measuring the reduction of body weight as a function of time.
TJ permeability assay. A TJ functional test was performed accord-
ing to methods developed previously (Chen et al., 1997) and was
adapted for skin (Furuse et al., 2002). 30 min after injection, the skin
was dissected out and frozen in optimum cutting temperature compound
(Tissue-Tek). About 10- m-thick sections were fixed as described pre-
viously (Furuse et al., 2002). Staining was visualized by an LSM confo-
cal microscope after the incubation of sections with streptavidin
AlexaFluor488 (Invitrogen) overnight at 4 C. Three wild-type and four
knockout mice were independently analyzed for this experiment.
Calculations and statistics
All data are expressed as means   SEM. Values of n refer to the number
of mice in each group. Individual groups were compared by using the t test
for all pair-wise comparisons. A level of P   0.05 was accepted as statis-
tically significant for all comparisons.
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